Abstract:Abdominal aortic aneurysm (AAA) is a serious vascular disease which is associated with vascular remodeling. CD38 is a main NAD+-consuming enzyme in mammals, and our previous results showed that CD38 plays the important roles in many cardiovascular diseases. However, the role of CD38 in AAA has not been explored. Here, we report that smooth-muscle-cell-specific deletion of CD38 (CD38SKO) significantly reduced the morbidity of AngII-induced AAA in CD38SKOApoe−/− mice, which was accompanied with a increases in the aortic diameter, medial thickness, collagen deposition, and elastin degradation of aortas. In addition, CD38SKO significantly suppressed the AngII-induced decreases in α-SMA, SM22α, and MYH11 expression; the increase in Vimentin expression in VSMCs; and the increase in VCAM-1 expression in smooth muscle cells and macrophage infiltration. Furthermore, we demonstrated that the role of CD38SKO in attenuating AAA was associated with the activation of sirtuin signaling pathways. Therefore, we concluded that CD38 plays a pivotal role in AngII-induced AAA through promoting vascular remodeling, suggesting that CD38 may serve as a potential therapeutic target for the prevention of AAA.

What problem does this paper attempt to address?

This paper aims to explore the role of CD38 in vascular smooth muscle cells (VSMCs), especially in the formation process of abdominal aortic aneurysm (AAA). Specifically, the researchers constructed a mouse model with smooth muscle cell - specific knockout of the CD38 gene (CD38SKO) to observe whether these mice could reduce the incidence of abdominal aortic aneurysm under the induction of angiotensin II (AngII) and explore the underlying mechanisms. ### Research Background Abdominal aortic aneurysm is a serious vascular disease, which is closely related to vascular remodeling. CD38 is the main NAD+ - consuming enzyme in mammals. Previous studies have shown that CD38 plays an important role in many cardiovascular diseases. However, the specific role of CD38 in abdominal aortic aneurysm has not been clearly defined. ### Research Objectives 1. **Verify the role of CD38 in abdominal aortic aneurysm**: Through the mouse model with smooth muscle cell - specific knockout of the CD38 gene, study the role of CD38 in AngII - induced abdominal aortic aneurysm formation. 2. **Explore the impact of CD38 knockout on vascular remodeling**: Analyze the impact of CD38 knockout on vascular remodeling indicators such as vascular wall thickness, collagen deposition, and elastic fiber degradation. 3. **Explore the impact of CD38 knockout on VSMC phenotype conversion**: Study whether CD38 knockout can inhibit AngII - induced VSMC conversion from contractile type to secretory type. 4. **Evaluate the impact of CD38 knockout on macrophage infiltration and inflammatory response**: Analyze whether CD38 knockout can reduce AngII - induced macrophage infiltration and inflammatory response. ### Main Findings 1. **CD38 knockout significantly reduced the incidence of AngII - induced abdominal aortic aneurysm**: The incidence of abdominal aortic aneurysm in CD38SKO mice was significantly lower than that in the control group. 2. **CD38 knockout inhibited vascular remodeling**: The vascular wall thickness, collagen deposition, and elastic fiber degradation in CD38SKO mice were all improved. 3. **CD38 knockout reversed the phenotype conversion of VSMC**: The VSMCs in CD38SKO mice maintained a higher expression of contractile - type markers such as α - SMA, SM22α and MYH11, while reducing the expression of Vimentin. 4. **CD38 knockout reduced macrophage infiltration and inflammatory response**: The expressions of macrophage markers F4/80 and CD68 in the blood vessels of CD38SKO mice were significantly reduced, and the MMP9 level was also decreased. ### Conclusion The research results show that CD38 plays a crucial role in AngII - induced abdominal aortic aneurysm formation, and participates in the pathogenesis of abdominal aortic aneurysm through promoting vascular remodeling, VSMC phenotype conversion, macrophage infiltration and other pathways. Therefore, CD38 may become a potential target for the prevention and treatment of abdominal aortic aneurysm.

Smooth-Muscle-Cell-Specific Deletion of CD38 Protects Mice from AngII-Induced Abdominal Aortic Aneurysm through Inhibiting Vascular Remodeling

CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice

Abstract 525: Angiotensin Ii Type 1a Receptor Deletion In Vascular Smooth Muscle Cells Prevent Abdominal Aortic Aneurysm Formation Induced By Angiotensin Ii Plus β-aminopropionitrile

Hypoxia Inducible Factor 2α Inhibition in Vascular Smooth Muscle Cells (vsmcs) Abolishes Abdominal Aortic Aneurysm in ApoE−/− Mice

Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice

Tributyrin Intake Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in LDLR-/- Mice

TRPV5 Attenuates Abdominal Aortic Aneurysm in Mice by Regulating KLF4-dependent Phenotype Switch of Aortic Vascular Smooth Muscle Cells.

Anemoside B4 attenuates abdominal aortic aneurysm by limiting smooth muscle cell transdifferentiation and its mediated inflammation

Interleukin‐38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2‐p38 pathway‐dependent manner

Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm.

Inhibition of miR-188-5p Suppresses Progression of Experimental Abdominal Aortic Aneurysms

MKL1 cooperates with p38MAPK to promote vascular senescence, inflammation, and abdominal aortic aneurysm

Targeting the Smooth Muscle Cell Keap1-Nrf2-GSDMD-pyroptosis Axis by Cryptotanshinone Prevents Abdominal Aortic Aneurysm Formation

ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in ApoE-/- mice

Disruption of TGF-β Signaling in Smooth Muscle Cell Prevents Elastase-Induced Abdominal Aortic Aneurysm

A reduction in the vascular smooth muscle cell focal adhesion component syndecan‐4 is associated with abdominal aortic aneurysm formation

Artesunate Attenuated the Progression of Abdominal Aortic Aneurysm in a Mouse Model

Dexmedetomidine Alleviates Abdominal Aortic Aneurysm by Activating Autophagy Via AMPK/mTOR Pathway

Adenosine Kinase Inhibition Protects Mice from Abdominal Aortic Aneurysm Via Epigenetic Modulation of VSMC Inflammation

SMAD3 deficiency promotes vessel wall remodeling, collagen fiber reorganization and leukocyte infiltration in an inflammatory abdominal aortic aneurysm mouse model

CircCDYL Contributes to Apoptosis, Ferroptosis, and Oxidative Stress of Ang II-Induced Vascular Smooth Muscle Cells in Thoracic Aortic Aneurysm